Last reviewed · How we verify
NCT07241000
Integrated Program to Enhance Professional Identity and Reduce Burnout in Neonatal Nurses
NA trial testing Integrated Empowerment and Narrative Nursing Program (I-ENP) in Professional Burnout in 172 participants. Completed in 1 October 2023.
1 July 2023
Quick facts
| Lead sponsor | The Fourth Hospital of Shijiazhuang |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 172 |
| Start date | 1 January 2023 |
| Primary completion | 1 July 2023 |
| Estimated completion | 1 October 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Integrated Empowerment and Narrative Nursing Program (I-ENP)
- Usual Care
Conditions studied
- Professional Burnout — all drugs for Professional Burnout →
Sponsor
The Fourth Hospital of Shijiazhuang
Who can join
Eligibility, any sex, with Professional Burnout. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This cluster randomized controlled trial evaluates the efficacy of an integrated empowerment and narrative nursing (I-ENP) program compared to usual care for neonatal nurses. The study aims to determine if the 6-month I-ENP, which includes empowerment education and narrative nursing sessions, can enhance professional identity, reduce burnout symptoms, and lower turnover intention among neonatal nurses.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07241000
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07241000 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Fourth Hospital of Shijiazhuang
- Last refreshed: 21 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07241000.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing